"AstraZeneca India and Abbott have mutually terminated the distribution agreement on May 27, 2021," AstraZeneca India said in a regulatory filing.from Moneycontrol Business News https://ift.tt/34pzPKP
Friday, May 28, 2021
AstraZeneca Pharma, Abbott Healthcare terminate distribution agreements for diabetes drug in India
"AstraZeneca India and Abbott have mutually terminated the distribution agreement on May 27, 2021," AstraZeneca India said in a regulatory filing.from Moneycontrol Business News https://ift.tt/34pzPKP
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment